Spots Global Cancer Trial Database for tumor treating fields
Every month we try and update this database with for tumor treating fields cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | NCT03940196 | Ovarian Cancer | NovoTTF-100L(O) Paclitaxel | 18 Years - | NovoCure Ltd. | |
| Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) | NCT00916409 | Glioblastoma Mu... | NovoTTF-100A de... Temozolomide | 18 Years - | NovoCure Ltd. | |
| Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) | NCT02973789 | Nonsmall Cell L... NSCLC | NovoTTF-200T Immune checkpoi... | 22 Years - | NovoCure Ltd. | |
| EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer | NCT04892472 | Non-small Cell ... | NovoTTF-200T Pembrolizumab (... | 22 Years - | NovoCure Ltd. | |
| EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma | NCT06390059 | Metastatic Panc... | Tumor Treating ... Atezolizumab Gemcitabine nab-paclitaxel | 18 Years - | NovoCure Ltd. | |
| Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | NCT03940196 | Ovarian Cancer | NovoTTF-100L(O) Paclitaxel | 18 Years - | NovoCure Ltd. | |
| Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
| Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) | NCT02973789 | Nonsmall Cell L... NSCLC | NovoTTF-200T Immune checkpoi... | 22 Years - | NovoCure Ltd. | |
| Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields | NCT03501134 | Malignant Gliom... | NovoTTF | 18 Years - | Duke University | |
| Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma | NCT03223103 | Glioblastoma | Poly-ICLC Tumor Treating ... Peptides | 18 Years - | Albert Einstein College of Medicine | |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) | NCT02397928 | Malignant Pleur... | NovoTTF-100L de... Pemetrexed Cisplatin or Ca... | 18 Years - | NovoCure Ltd. | |
| Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery) | NCT04223999 | Recurrent Gliob... | Skullremodeling... Control | 18 Years - | University of Aarhus | |
| Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
| Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data | NCT06346821 | Glioblastoma Mu... | Optune® (Tumor ... | 18 Years - | Sichuan University | |
| Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) | NCT03377491 | Pancreas Adenoc... | NovoTTF-200T Gemcitabine nab paclitaxel | 18 Years - | NovoCure Ltd. | |
| Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer | NCT05679674 | Pancreas Cancer Locally Advance... Locally Advance... | Stereotactic Ab... Tumor Treating ... | 18 Years - | Baptist Health South Florida | |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) | NCT02397928 | Malignant Pleur... | NovoTTF-100L de... Pemetrexed Cisplatin or Ca... | 18 Years - | NovoCure Ltd. | |
| TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study | NCT04717739 | Glioblastoma | TTFields | 18 Years - | NovoCure Ltd. | |
| TTField in Combination With TMZ and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. | NCT06353360 | Glioblastoma Mu... | Tumor Treating ... Tislelizumab Temozolomide (T... | 18 Years - | Jiangsu Healthy Life Innovation Medical Technology Co., Ltd | |
| Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma | NCT04281576 | Gastric Cancer GastroEsophagea... | NovoTTF-100L(P) Oxaliplatin Capecitabine Trastuzumab | 18 Years - | NovoCure Ltd. | |
| TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM | NCT03780569 | Glioblastoma Mu... | NovoTTF-200A Radiotherapy Temozolomide | 18 Years - | NovoCure Ltd. | |
| TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study | NCT04717739 | Glioblastoma | TTFields | 18 Years - | NovoCure Ltd. | |
| Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM | NCT03705351 | Glioblastoma Cancer of Brain Glioblastoma Mu... Brain Tumor | Tumor Treating ... Temozolomide Radiation Thera... | 22 Years - | Providence Health & Services | |
| TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM | NCT03780569 | Glioblastoma Mu... | NovoTTF-200A Radiotherapy Temozolomide | 18 Years - | NovoCure Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
